SCHEMBL21395915

SCHEMBL21395915

N#Cc1ccc(-c2ccc3c4ccc(-c5cc6cccnc6c6ncccc56)cc4n(-c4ccccc4)c3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP1 P07148 1/20 0.38
TDP2 O95551 1/20 0.36
METAP2 P50579 1/20 0.36
ATM Q13315 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PGR P06401 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CCR1 P32246 2/20 0.35
CCR8 P51685 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
PDPK1 O15530 1/20 0.35
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
PARP1 P09874 1/20 0.34
TGFBR1 P36897 1/20 0.34
CHEK1 O14757 1/20 0.34
PDE4A P27815 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396160 0.98 FABP1 (0.40) FABP1TDP2ATMMEN1KMT2A
SCHEMBL21395913 0.94 FABP1 (0.38) FABP1TDP2METAP2ATMMEN1
SCHEMBL21395914 0.88 PDE4D (0.40) FABP1ABCG2PDE4APDE4CPDE4D
SCHEMBL16520864 0.86 TDP2 (0.36) FABP1TDP2METAP2ATMMEN1
SCHEMBL16558156 0.83 FABP1 (0.41) FABP1TDP2METAP2MEN1KMT2A
SCHEMBL21395917 0.83 PARP1 (0.42) FABP1TDP2METAP2PGRCCR1
SCHEMBL16558144 0.82 FABP1 (0.42) FABP1TDP2METAP2MEN1KMT2A
SCHEMBL16456283 0.80 TDP2 (0.37) FABP1TDP2ATMSMN1; SMN2CCR1
SCHEMBL16455812 0.79 FABP1 (0.41) FABP1TDP2METAP2MEN1KMT2A
SCHEMBL16560653 0.79 FABP1 (0.41) FABP1TDP2METAP2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, PPOX, SUN2 FABP1 4775/4885TDP2 1980/4885METAP2 2809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.